Catalyst Wire Dossier Catalyst Wire Dossier

PD-L1 t-haNK

· ImmunityBio, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PD-L1 t-haNK, covering 2026-02-12 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers [Phase 1]

See pricing